Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01514
|
|||||
| Drug Name |
Bunitrolol
|
|||||
| Synonyms |
Bunitrolol; 2-(3-(tert-Butylamino)-2-hydroxypropoxy)benzonitrile; Bunitrolol [INN]; Stresson; Bunitrololum [INN-Latin]; KO-1366; Bunitrolol HCl; BRN 2374567; 2-Nitrilo-N-tert-butylphenoxypropanolamine; Koe 1366; o-(3-(tert-Butylamino)-2-hydroxypropoxy)benzonitrile; 2-Propanol, 3-(tert-butylamino)-1-(m-cyanophenoxy)-; (RS)-2-(3-(tert-Butylamino)-2-hydroxypropoxy)benzonitril; 2-[3-(tert-butylamino)-2-hydroxypropoxy]benzonitrile; Bunitrololum; BENZONITRILE, o-(3-(tert-BUTYLAMINO)-2-HYDROXYPROPOXY)-
|
|||||
| Indication | Discovery agent [ICD11: N.A.] | preclinical | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C14H20N2O2
|
|||||
| Canonical SMILES |
CC(C)(C)NCC(COC1=CC=CC=C1C#N)O
|
|||||
| InChI |
InChI=1S/C14H20N2O2/c1-14(2,3)16-9-12(17)10-18-13-7-5-4-6-11(13)8-15/h4-7,12,16-17H,9-10H2,1-3H3
|
|||||
| InChIKey |
VCVQSRCYSKKPBA-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 34915-68-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 248.32 | Topological Polar Surface Area | 65.3 | ||
| Heavy Atom Count | 18 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
1.9
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:135012
|
|||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Extrapolating in vitro metabolic interactions to isolated perfused liver: predictions of metabolic interactions between R-bufuralol, bunitrolol, and debrisoquine. J Pharm Sci. 2010 Oct;99(10):4406-26. | |||||
| 2 | Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrier. Biopharm Drug Dispos. 1999 Mar;20(2):85-90. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.